(Q113896317)
Statements
A Phase 1, Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenously Administered AVLX-144 (English)
0 references
27 December 2020
0 references
20 February 2021
0 references
48
0 references
20 year
0 references
80 year
0 references